RUSSO, Simonetta
 Distribuzione geografica
Continente #
NA - Nord America 1.653
AS - Asia 1.442
EU - Europa 1.279
SA - Sud America 223
AF - Africa 86
Totale 4.683
Nazione #
US - Stati Uniti d'America 1.606
SG - Singapore 468
CN - Cina 421
FI - Finlandia 273
VN - Vietnam 253
IT - Italia 241
DE - Germania 213
IE - Irlanda 188
BR - Brasile 180
SE - Svezia 158
HK - Hong Kong 81
TR - Turchia 64
FR - Francia 63
ZA - Sudafrica 52
GB - Regno Unito 34
BD - Bangladesh 32
NL - Olanda 30
IN - India 23
CI - Costa d'Avorio 21
CA - Canada 19
AR - Argentina 18
MX - Messico 18
UA - Ucraina 15
BE - Belgio 14
JP - Giappone 14
ID - Indonesia 13
IQ - Iraq 11
RU - Federazione Russa 11
CZ - Repubblica Ceca 9
EC - Ecuador 8
JO - Giordania 7
KR - Corea 7
PH - Filippine 7
PK - Pakistan 7
TH - Thailandia 7
HU - Ungheria 6
LT - Lituania 6
MA - Marocco 6
AZ - Azerbaigian 5
VE - Venezuela 5
AT - Austria 4
BO - Bolivia 4
ES - Italia 4
UZ - Uzbekistan 4
PL - Polonia 3
SA - Arabia Saudita 3
TW - Taiwan 3
CL - Cile 2
CO - Colombia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
LK - Sri Lanka 1
LV - Lettonia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
ZM - Zambia 1
Totale 4.683
Città #
Singapore 258
Chandler 191
Ashburn 189
Dublin 188
San Jose 135
Munich 130
Ann Arbor 114
Parma 112
Beijing 109
Santa Clara 102
Dallas 94
Ho Chi Minh City 79
Hong Kong 75
Helsinki 58
Hanoi 52
Boardman 51
Dearborn 51
Johannesburg 51
Izmir 47
New York 42
Shanghai 41
Los Angeles 39
Nanjing 39
Jacksonville 30
Princeton 28
Bremen 27
Lauterbourg 24
Wilmington 24
Abidjan 21
São Paulo 19
Buffalo 14
Columbus 14
Council Bluffs 14
Brussels 13
Kunming 13
Shenyang 13
Da Nang 12
Rio de Janeiro 12
Hebei 11
Hefei 11
Nanchang 11
Tokyo 11
Düsseldorf 10
San Mateo 10
Turku 10
Guangzhou 9
Haiphong 9
Jakarta 9
Toronto 9
Grafing 8
Hangzhou 8
Jinan 8
Kocaeli 8
Mexico City 8
Orem 8
Poplar 8
Seattle 8
Amman 7
London 7
Montreal 7
Moscow 7
Springfield 7
Stockholm 7
Ankara 6
Chennai 6
Denver 6
Fremont 6
Jiaxing 6
Milan 6
Modena 6
The Dalles 6
Tianjin 6
Zhengzhou 6
Baku 5
Belo Horizonte 5
Brasília 5
Brooklyn 5
Changsha 5
Frankfurt am Main 5
Fuzhou 5
Houston 5
Manchester 5
Prata Di Pordenone 5
Quito 5
Rome 5
San Francisco 5
Woodbridge 5
Boston 4
Can Tho 4
Chicago 4
Des Moines 4
Hyderabad 4
Lubbock 4
Manaus 4
Nuremberg 4
Olomouc 4
Palermo 4
Pune 4
Sant'ilario D'enza 4
Tashkent 4
Totale 2.923
Nome #
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey 296
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 243
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 222
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 217
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 213
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 208
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 201
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction 198
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 197
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 185
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 176
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors 168
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 163
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 161
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 156
Structure activity relationship of new EphA2 ligands 150
Design and structure-activity relationships of amino acid derivatives of lithocholic acid as novel EphA2 receptor antagonists. 148
Mannich base derivatives as novel EGFR irreversible inhibitors 148
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 148
Combining pharmacology, target hopping and computational medicinal chemistry to discover novel scaffold targeting EPH-ephrin interaction. 148
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 145
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 138
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists 135
Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism 134
Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor. 125
Target-hopping: a useful approach to identify novel Eph receptor antagonists 125
Mechanical vibrations applied to nondestructive evaluation of materials and structures 109
Structure-activity realtionships of new EphaA2 ligands 90
Totale 4.747
Categoria #
all - tutte 14.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022179 9 10 9 38 4 11 14 11 5 12 8 48
2022/2023668 75 84 25 53 70 75 12 36 219 4 13 2
2023/2024219 16 16 5 9 8 35 32 21 10 10 21 36
2024/2025897 27 50 50 53 92 104 108 56 111 56 68 122
2025/20261.727 158 172 155 157 233 115 176 58 278 134 87 4
Totale 4.747